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INTRODUCTION 
         Rheumatoid Arthritis (RA) is the most common systemic 
inflammatory, auto immune Rheumatic disease of unknown 
etiology1,2,3,4  affecting nearly 1% 1,3,5,6,7,8.9,10 of the adult population 
worldwide. It is characterized by chronic and erosive 
polyarthritis,10,11 (usually involving small, peripheral joints in a 
symmetric distribution) caused by abnormal growth of synovial 
tissue or pannus, and causes irreversible joint deformity9 that can 
lead to severe disability1,3,8,12,13 with considerable morbidity6. 
Although the precise aetiology of RA remains unknown1, there is 
strong evidence for autoimmunity, since several auto antibodies are 
associated with the disease6. 
             The potential of the synovial inflammation to cause 
cartilage damage and bone erosions and subsequent changes in joint 
integrity is the hallmark of the disease. Despite its destructive 
potential, the course of RA can be quite variable. Some patients 
may experience only a mild oligo articular illness of brief duration 
with minimal joint damage, but most will have a relentless 
progressive polyarthritis with marked functional impairment. 
                The disease occurs frequently in women than in men        
(2.5 – 3:1). It afflects the people of all races equally. The disease can 
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begin at any age, peak onset typically occurs in the fourth and fifth 
decades of     life.7 
               In some families, multiple members can be affected, 
suggesting a genetic basis for the disorder. Genetic studies have 
demonstrated that a genetic predisposition resides in the HLA-DR 
locus7,12. There is also evidence that environmental factors, such as 
infectious agents, oral contraceptives and smoking, may play a role7.               
For decades, RA is diagnosed primarily according to clinical  
manifestations  based  upon  ACR  criteria 3,5,7,14,15, in   which  the  only  
serological   marker is  RF  test. 
                Rheumatoid factor (RF) is an antibody directed against the 
Fc region of IgG that has been used as a diagnostic marker for 
Rheumatoid Arthritis.2,3,6,7,16. and is recommended as a screening test3.  
and  can be detected in up to 80% of RA patients 6,17.However it is 
nonspecific16  and may be present in 5-10 % of healthy elderly persons 
or  in  patients  with other autoimmune and infectious diseases2,6,11.The 
test is performed  on a   routine  basis  in most clinical laboratories1,7 as 
per ACR criteria.  
               During  the   first  few  months  of   the  disease,  the  (1987) 
revised criteria of   the  American College of Rheumatology  (ACR) is 
rarely  met.  About  one- third  of  the patients  with persistent  arthritis 
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do  not   fulfill  the   classification criteria,  so  it  is often  difficult  to  
diagnose  RA, in the very early stages  of  the  disease6. On  the  other  
hand, numerous studies have shown that substantial irreversible joint 
damage  occurs within the first 2 years 6,18,19  of the disease. In many 
cases, irreversible  damage of  the  joint  cartilage  has  already 
occurred by    the time laboratory and radiological parameters have 
confirmed the clinical diagnosis of RA. 
               So it is therefore crucial to have a reliable and  specific test to 
identify the RA patients prior to the occurrence of  joint   damage.17The  
other  most  specific  auto antibody system for RA is the family of auto 
antibodies directed to Citrulline – containing proteins, including    
antiperinuclear  factor   (APF) in 19647, antikeratin  antibodies (AKA) 
in 1979,7 antifilaggrin  antibodies  (AFA)  and  anti-Sa3,7,11. Because  of   
rigorous  technical  requirements  for their   detection,  antiperinuclear  
factor and antikeratin antibodies have never  been widely used as 
markers for Rheumatoid Arthritis, despite  their  high  specificity3,6.                            
Recently,   a   new   serological   test   (biological  marker) 20  the   anti  
Cyclic Citrullinated Peptide  (anti-CCP) 2,20  was developed6. Citrulline   
is formed by deamination of arginine residues  in several  proteins  by    
the   action  of  enzyme peptidyl  arginine  deiminase (PAD) 6,7,16,21,20   
which  is  present  abundantly   in  inflammatory synovium  &  cause   
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local citrullination of proteins such as fibrin6,7.Citrullinated    
extracellular fibrin in the RA synovium may be one of the major   
autoantigens driving local immune response suggested by the 
discovery of   local   production   of   anti – CCP   antibodies   in   the   
joint. 
              The  test  could  also  be  helpful  in  the diagnosis of RA in 
those cases  that do not completely fulfil the 1987 ACR criteria.7       
Anti –CCP  was  reported to have a higher specificity for the  diagnosis 
of RA,especially in patients with early disease .3,10 Anti CCP antibodies  
are diagnostic & prognostic marker of early onset of RA,and predate 
arthritis by  several   years.6,,21,22 
                It was also found that there is an association between anti - 
CCP and the disease severity in early RA6,11,23. A-CCP  is the predictor 
of   bone  damage.3,7,23  
              The high specificity (98%) of anti-CCP in patients with RA 
can  exclude other rheumatic or immune diseases,6,7,9 (like  SLE  &  
OA) in   patients with positive  anti- CCP.   
               20% of new patients with RA are seronegative in the 
firstyear,when early diagnosis  is  essential  to  prevent  erosive  joint 
disease7,18,24. It   have  been  helpful to see the anti-CCP data during the 
first, vitally important year of  disease. 
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              Around 40 % of RF seronegative patient appear to be        
anti–CCP  positive,which substantiates additional diagnostic potential 
of anti-CCP. Specificity of anti -CCP antibodies is more than 90 %.     
It has been recognised in the last decade, RA needs to be diagnosed 
early & treated promptly with Disease Modifying Anti Rheumatic 
Drugs (DMARD) in  order to successfully interfere with disease 
process18,19.The ultimate challenge for  future  is  to  initiate   therapy  
in  early  phase that the actual development of RA  is  prevented, for 
which early diagnosis is more important to  limit  the  radiological  
progression  of  the  disease  (bony deformity)  by initiating  treatment  
earlier  and  also important  for  providing  patients  with best  outcome 
& quality of life16. It   is  useful  in diagnosis  and  exclusion  of  RA.24.             
               Another potential marker for increased risk of  RA may be  C- 
reactive  protein(CRP).11,18,21,22 may also be elevated in patients with  
RA.17,22,23,25Additionally ESR is also determined in patients with 
RA11,22,23,25. Hence the  study. 
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AIMS  & OBJECTIVES 
 
 Aim: 
        The aim of the present study is to evaluate the use and 
significance of AntiCCP  antibodies  in  Rheumatoid  Arthritis, and  to  
compare  it  with  other  Arthritis - Early Synovitis (ES), Connective 
Tissue Disorders (CTD) including SLE, and Osteo Arthritis (OA), and 
in Healthy Blood Donors as control. 
 
Objectives: 
• To evaluate the diagnostic utility of   Anti- CCP (cyclic 
citrullinated peptide) antibody in Rheumatoid arthritis. 
• To study & compare the presence of Anti- CCP antibody in 
Rheumatoid arthritis (RA) with other arthritis. – Early 
Synovitis (ES),Connective Tissue Disorders (CTD) including 
SLE, and Osteo Arthritis (OA). 
• To evaluate the significance of Anti- CCP antibody in Sero 
Negative Rheumatoid Arthritis.              
• To assess the sensitivity and specificity of the Anti CCP 
antibody test with RF test in RA and other arthritis. 
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REVIEW OF LITERATURE 
History 26  
   The 1st known traces of arthritis date back at least as far as 4500 BC. 
• A text dated 123 AD first describes symptoms very similar to 
Rheumatoid arthritis. 
 The art of Peter Paul Rubens may possibly depict the effects 
of Rheumatoid arthritis. 
• The first recognized description of rheumatoid arthritis was in 
1800  by the French physician Dr Augustin Jacob Landré - 
Beauvais (1772-1840).  
• The name "Rheumatoid Arthritis" itself was coined in 1859 by 
British Rheumatologist Dr Alfred Baring Garrod.  
• 1937 – RF-"Rheumatoid  Factor” Erik waaler 2,13  
• 1964 – APF-anti perinuclear antibody 7,13,27 - Neinhuis and 
Mandema9 
• 1979 – AKA-anti keratin antibody.7,13,27  
• Walther van venrooij and colleagues –A CCP- anti cyclic 
citrullinated peptide.2 
Affected famous personalities26 
• Auguste Renoir, impressionist painter, whose later 'softer' style 
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might have reflected in some way his severe disability. 
• Christiaan Barnard, the first surgeon to perform a human-to-
human heart transplant had to retire owing to the condition. He 
also wrote a book on living with arthritis. 
• James Coburn claimed to have healed the condition using pills 
containing a sulfur-containing compound on his return to acting. 
• Erik Lindbergh, aviator and member of the X-Prize 
administration. Erik has been a spokesman for the arthritis drug 
Enbrel, as a result of his success with the treatment.  
• Kathleen Turner and Aida Turturro have worked to raise public 
awareness of the condition. 
• Billy Bowden, international cricket umpire who had to retire 
from active playing due to RA. 
• Melvin Franklin, bass singer of the Temptations. He was treated 
for RA with cortisone shots so he could perform. 
• Christopher Lee, British actor, used special, ergonomically 
designed props when he works on set. 
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RHEUMATOID ARTHRITIS 
               The name is based on the term "Rheumatic Fever" an illness 
which includes joint pain and is derived from the Greek word 
Rheumatos ("flowing").  The suffix - oid ("resembling") - joint 
inflammation that resembles rheumatic fever. 26 
              Rheumatoid Arthritis (RA) is the commonest inflammatory 
joint disease.1,2,3  It is characterized by chronic polyarthritis in 
symmetrical distribution with multiple deformities and systemic 
involvement.11,25,28,29 This leads to irreversible joint disability.25 It is 
associated with considerable morbidity6.  
              RA is characterized by inflammation of the synovial 
membrane of diarthrodial joints7. Early indications of RA are swelling 
and pain of the proximal interphalangeal and metacarpophalangeal 
joints. Later, the larger joints become affected, especially those of the 
knee, elbow and ankle7. Many studies show that the synovial 
membrane inflammation, in most cases lead to progressive destruction 
of cartilage and bone leading to irreversible deformity and 
disability1,3,8,12,13. In a study by A.J.W.Zendman, et al ,says that  RA 
severely affects the quality of life16 of a patient and also has major 
economic consequences for society. 
             Since RA is a systemic autoimmune disease, other parts or 
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organs of the body may become affected at a later stage, example - 
Rheumatoid Nodule7,30,31. 
Etiology 
      Although the precise etiology of RA remains unknown1,2,6  there is 
strong evidence for autoimmunity since several auto antibodies are 
associated with the disease.6,30,31                              
      Family studies indicate a genetic predisposition. Severe RA is 
found at approximately 4 times the expected rate in first-degree 
relatives of individuals with disease associated with the presence of the 
autoantibody6, Rheumatoid factor.  Moreover, monozygotic twins are 
at least four times more likely to be concordant for RA than dizygotic 
twins. 23 
        Genetic studies have demonstrated that a genetic predisposition 
resides in the HLA-DR locus as reported in many studies and 
texts7,12,30,31. HLA-DR 1 is more important in Indians, and HLA-DR 15 
in Japanese. As reported by CDC review, it is strongly associated with 
the inherited tissue type Major Histocompatibility Complex (MHC) 
antigen HLA-DR4 in more erosive disease 27,31,32 (most specifically 
DR0401 and 0404)4, 40. Hence family history is an important risk 
factor. 
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Risk factors: 7,22,32    
       A range of environmental and genetic variables have been 
evaluated as potential risk factors for RA 
• Hormonal exposures 
• Tobacco use33 
• Dietary components 
• HLA genotype, and  
• Microbial exposures 
But to date no definitive risk factors for RA have been identified.  
Epidemiology26,31,32 
RA is seen throughout the world and affects all races. 
        Disease prevalence is similar to that of developed countries, but 
higher than reported from China, Indonesia, Phillippines, and Rural 
Africa. North Indian population is genetically closer to Caucasians (1-
1.5%) 31,34 than to other ethnic groups.35 Higher prevalence rates  in 
pima group of Indians of Arizona31 & in some Native American groups 
have (5-6%). And people from the Caribbean region & black Africans, 
have lower prevalence rates .31,34 
         Mahajan et al,in his study around Kashmir, in 2003, reported 23.9 
%  had Rheumatological problems, 24.9% had OA.36  
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          The  prevalence  rate is 1%.1,3,5,6,7,8,9,28. Before the age of  45years  
the female, male ratio is 6:1. Women are affected   three to five times 
as often as men. (3 - 5:1ratio)7,25 suggesting a role for sex hormones.   
(0.5 -3.8% in women ,1.37 % in men.) 24. The incidence of RA is six 
times greater in old women compared to young women.   
          The  prevalence  increases with age in  5 %  of  women, and 
2%of men over 55 years,31 and sex differences diminish in the older 
age.Onset is most frequent during  the  fourth and fifth decades of life7. 
With 80% of all patients developing the disease between the ages of 35 
and 50 years, as shown in study by Athena Linos et al 33. Mean ages of 
RA patients ranged  from 50.0 to 52.2 yrs and % of female patients 
from 80.9% to 89.6%.It is 4 times more common in smokers  than non-
smokers.37  
          As  per   CDC 40  an    estimated  1.293   million   adults  aged 18 
and  older (0.6%) had RA in 2005, down from the previous 1990 
estimate of 2.1 million. The prevalence among women in 1995 was 
approximately double that in men (1.06% versus 0.61%).32 This study 
observed almost a 2:1 ratio in prevalence for women to 
men.Prevalence is decreasing now.32 
        Genetic concordance in monozygotic twins is approximately 12-
15%31. First-degree   relative’s   prevalence   rate   is 2-3%31. 
13 
 
Pathogenesis 26,31   
     It is characterised by   
• Persistent cellular activation 
• Auto immunity 
• Presence  of immune complexes at articular and extra 
articular sites.  
  This    leads to  
• Chronic inflammation 
• Granuloma 
• Joint  destruction.           
         Microvascular injury, thrombosis, and neovascularization with 
edema and infiltration by lymphocytes (CD4 Tcells), plasma cells and 
macrophages often collected into aggregates around small blood 
vessels.26 Locally produced antibodies to tissue components and 
immune complexes can activate complement and generate 
anaphylatoxins and chemotactic factors.T cells produce cytokines such 
as IFN. It remains unclear whether the persistent T cell activity 
represents a response to a persistent exogenous antigen or to altered 
autoantigens such as collagen, immunoglobulin, one of the heat shock 
proteins, or CCP. 
14 
 
           Effusion of synovial fluid into joint space, hypertrophy and 
congestion of synovial membrane and underlying connective 
tissue.Inflammatory granulation tissue-pannus, spreads over and under 
the articular cartilage with formation of lymphoid follicles resembling 
lymph node (granuloma), progressively erodes and destroys the bone. 
Adjacent muscles get inflammed due to infiltration. 
Immunofluorescence  confirms the Rheumatoid Factor auto antibody 
synthesis by plasma cells in synovium and lymph node.31                 
           Recent evidence suggests that antibodies may be produced 
against  other self-antigens, such as CCP, which are generated within 
the synovium, and  this  may contribute to RA synovitis.  
RA-associated autoantibodies (RF): 
            Throughout the last decades several autoantibody systems have 
been described that are associated with RA. 
            RF - the oldest and most widely known of these autoantibodies, 
is directed to the Fc part of IgG molecules.3,6,7,16  RF can be detected in 
up to 80% of RA patients,8,17  but the studies by Swedler et al, and 
Nehir samanchi et al shows, these antibodies are found also in several 
other auto immune diseases as well as in healthy individuals -  5-10 % 
6,11  (especially elderly) lowering its specificity for RA.6,11,8 
           The frequency of Rheumatoid Factor in the general population 
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increases with age, and 10–20% of individuals > 65 years have a 
positive test. In addition, a number of conditions besides RA are 
associated with the presence of RF. These include Systemic Lupus 
Erythematosus, Sjogren's syndrome, chronic liver disease, Sarcoidosis, 
Interstitial Pulmonary Fibrosis, Infectious Mononucleosis, Hepatitis B, 
Tuberculosis, Leprosy, Syphilis, Subacute Bacterial Endocarditis, 
Visceral Leishmaniasis, Schistosomiasis, and Malaria.Due to the above 
factors RF’s diagnostic specificity has lowered. 
           So the presence of Rheumatoid Factor does not establish the 
diagnosis of RA. Therefore  the RFactor test alone is not useful as a 
screening procedure. Both anti-CCP antibody and RF are 
recommended screening tests for Rheumatoid Arthritis.3 
            A negative RF does not rule out RA, rather the arthritis is 
known as seronegative. This is the case in about 15% of patients. Up 
to 20% of new patients with RA are seronegative in the first year, when 
early diagnosis is essential to prevent erosive joint disease38. Previous 
studies  show, around 40% of RF-seronegative patients appear to be 
anti-CCP-positive. This substantiates the additional diagnostic 
potential of CCP.8,4,16,39 
RA-Specific Autoantibodies 
          The autoantibody systems with the greatest clinical potential for 
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RA are the antibodies directed to citrulline containing epitopes6,7 
            The presence of autoantibodies against citrullinated proteins in 
RA patients was first described in the mid-seventies when the 
biochemical basis of antibody reactivity against keratin and filaggrin 
was investigated, APF (antiperinuclearantibodies) - 1964, AKA 
(antikeratin antibodies) -1979, though specific because of technical 
difficulties not widely used. Recently Anti Cyclic citrullinated peptides 
(Anti CCP) detected with high sensitivity and specificity for RA.6 
Citrulline: 
            During inflammation, the enzyme peptidylarginine deiminase 
incorporates citrulline into proteins, the enzymatic conversion of 
peptidyl-arginine to peptidyl-citrulline.   
                                                      
           Citrulline has been named after the Latin word for 
watermelon,Citrullus vulgaris, whichcontains large amounts of this 
amino acid.  
            Citrulline  is a non standard amino acid, as it is not 
incorporated into proteins during protein synthesis. “Cyclic 
citrullinated peptide" is also known as "CCP". It is a cyclic peptide, 
can incorporate the amino acid citrulline and can be generated via post 
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translational modification of arginine residues by peptidyl arginine 
deiminase (PAD) enzymes.5,6,7,10,16,21  
              PAD enzymes are present in the inflamed synovium and that 
their activity is regulated at  the transcriptional and translational levels 
In addition, these enzymes require relatively high Ca2+ concentrations,  
about 100 times higher than normally present in the cytosol of a   
living cell.6,7    
              Conversion of arginine into citrulline involves the 
replacement of an amine group by an oxygen atom in the side chain of 
this amino acid, and is associated with the loss of a positive charge (at 
neutral pH). The neutral oxygen group of the citrulline residue is the 
part that is recognized by the autoantibodies. 
              Interestingly, citrullination occurs primarily in dying cells. 
Indeed, during inflammation, when many cells die by apoptosis or 
necrosis, in the inflamed synovia of RA and non-RA patients. 
Paradoxically, the presence of citrullinated proteins in most cases does 
not lead to the generation of anticitrullinated protein antibodies. This 
phenomenon might be related to the genetic background of the patient. 
It has been known for some time that there is a rather strong 
correlation between RA and certain HLA-DR alleles, particularly 
HLADRB1- 0401 and HLA-DRB1- 0404)6.                                
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Citrulline antibody: 40,41  
           It is an antibody (an immune protein) directed against a circular 
peptide (a ring of amino acids) containing an unusual ("non-standard") 
amino acid called citrulline that is not normally present in peptides or 
proteins. 
          It is frequently detected in RA is patients. Recently, these 
antibodies have turned up as powerful biomarkers, which are accepted 
as a major diagnostic tool in diagnosing RA in a very early stage of 
disease.                 
Clinical Features 26,30,31 
          Complaints of pain over the affected joints, symmetrical joint 
involvement and morning stiffness, with characteristic changes of the 
hand including  
• Radial deviation at the wrist with ulnar deviation of the 
digits, often with palmar subluxation of the proximal 
phalanges ("Z" deformity). 
• Hyper extension of the proximal interphalangeal joints, with 
compensatory flexion of the distal interphalangeal joints 
(swan-neck deformity). 
• Flexion contracture of the proximal interphalangeal joints 
and extension of the distal interphalangeal joints 
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(boutonnière deformity), and 
• Hyperextension of the first interphalangeal joint and flexion 
of the first metacarpophalangeal joint with a consequent loss 
of thumb mobility and pinch.                                             
Typical joint changes may also develop in the feet, including 
• Eversion at the hind foot (subtalar joint) 
• Plantar subluxation of the metatarsal heads 
• Widening of the forefoot 
• Hallux valgus, and lateral deviation and dorsal subluxation 
of the toes.  
Later, disability is more related to structural damage to articular 
structures. 
Disability 
• Daily living activities are impaired in most individuals. 
• After 5 years of disease, approximately 33% of sufferers will 
not be working. 
• After 10 years, approximately half will have substantial 
functional disability. 
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Prognostic factors 4,32,31 
Poor prognostic factors include4  
• Persistent synovitis 
• Early erosive disease 
• Extra-articular findings (including subcutaneous rheumatoid 
nodules) 
• Positive serum RF findings   
• Positive serum anti-CCP autoantibodies 
• Carriership of HLA-DR4 "Shared Epitope" alleles  
• Family history of RA 
• Poor functional status 
• Socioeconomic factors  
• Elevated acute phase response ESR 
• Elevated C-reactive protein [CRP] 
• And increased clinical severity 
Mortality32 
           Estimates  of   the  life-shortening    effect   of  RA   vary. Most  
sources  cite a  lifespan reduction of 5 to 10 years.  
Laboratory diagnosis: 
          Currently, the classification of RA relies mainly on the criteria 
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described by the American College of Rheumatology (ACR). 1,5,7,14,15 
These criteria, originally formulated 50 years ago and last adjusted in 
198725  are based mainly on clinical parameters and a single serological 
test RF. Since these parameters are often only sufficiently fulfilled 
when the damaging effects of the inflammatory process are already in 
progress, this set of criteria is not very suitable for the early diagnosis 
of RA .In the ACR criteria for RA serologic support is restricted to the 
determination of Rheumatoid Factor (RF).42 RF(1937) has been widely 
used as a screening test for patients with arthritis3. However, its 
diagnostic specificity for RA is poor, since RF is also found in many 
other rheumatic and non rheumatic diseases, infectious conditions and 
even in a noticeable proportion of normal healthy subjects, particularly 
in ageing individuals6,11,25 .The resulting lack of specificity for RA can 
lead to  wrong diagnosis and unwanted treatment.  
                However, especially during the first few months of the 
disease, the 1987 revised criteria of the ACR are rarely met.About one-
third of the patients with persistent arthritis do not fulfill the 
classification criteria,so it is often difficult to diagnose RA in the very 
early stages of the disease 25. 
                On the other hand, numerous studies have shown that 
substantial irreversible joint damage occurs within the first 2 years .In 
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many cases, irreversible damage of the joint cartilage has already 
occurred by the time laboratory and radiological parameters have 
confirmed the clinical diagnosis RA.So it is important to start 
treatment earlier. Current therapeutic strategies in RA are with 
increasingly aggressive regimens.Therefore, diagnostic tests with high-
specificity are desirable for deciding on the optimal treatment25.                      
                 Missed diagnosis of  Rheumatoid Arthritis (RA) has major 
medical and cost implications, since this set of ACR criteria is not very 
suitable for the early diagnosis of RA.A specific and sensitive 
(serological) marker, which is present very early in the disease, is 
needed which should ideally be able to predict the erosive or 
nonerosive progression of the disease25. 
                 The shortcomings of the RF test have kept the search for 
more specific RA markers alive. Most autoantibody systems described 
during recent decades, Anti Perinuclear Factor (APF) – 1964, and Anti 
Keratin Antibody (AKA) tests – 1979 3,7,11 have failed to mature into 
mainstream tests for RA because of low sensitivity, and technical 
inconvenience 6,3.  
                  Another group of autoantibodies have recently been 
detected in serum of patients  with  RA, in which patients develop 
antibodies to modified (citrullinated) arginine residues, and this has 
23 
 
resulted in the development of the anti-cyclic citrullinated peptide 
antibodies (anti CCP). The only antibody system that combines good 
sensitivity with superior specificity for RA is that targeting 
citrullinated epitopes. 
               Antibodies to CCP (anti-CCP) can also be used to evaluate 
patients with RA. Although these antibodies are most commonly found 
in Rheumatoid Factor–positive patients, on occasion they can be 
detected in the absence of Rheumatoid Factor. In addition, the anti-
CCP  test has a similar sensitivity and a better specificity for RA than 
R F34 When the citrulline antibody is detected in a patient's blood, there 
is 90-95% likelihood that the patient has Rheumatoid Arthritis40. 
               The presence of anti-CCP is associated with the aggressive 
nature of the disease, with a tendency for developing bone erosions. It 
is most useful to confirm the diagnosis and establish a likely prognosis. 
A role in differential diagnosis comes from patients with erosive 
systemic lupus erythematosus (SLE) other arthritis and excludes 
them.The combined presence of  RF positivity and anti-CCP positivity 
has 99.5% specificity for RA 43.  
                 The value of anti-CCP antibodies and RF for predicting 
the outcome of RA, clinical signs of disease activity, and the 
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severity of radiologic joint damage has been investigated recently. 
The studies by van Jaarsveld et al, Kroot et al, and Meyer et al, all 
support the thesis that RA patients, positive for CCP, develop 
significanly more radiological damage than CCP-negative 
patients.Lately, Visser et al, assessed a clinical prediction model in 
early RA patients for the three forms of arthritis out come: self-
limiting, persistent nonerosive and persistent erosive arthritis in 
which CCP was strongly associated with erosive arthritis, more than 
RF.             
 “RA passport” should contain  
• Serological data (RF, OR and anti-CCP2) 
• Genetic data       (e.g. HLA-DR4) and  
• Several clinical parameters,  
as suggested  by Visser and coworkers 17. 
Investigations 30, 31 
1.Neutrophils   
 Increase in systemic vasculitis, sepsis & decrease in rheumatoid 
arthritis, lupus & drugs.  
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2.Lymphocytes 
Increase in infections, decrease in lupus, and in those with 
corticosteroid therapy. 
3.Eosinophils   
Increase in systemic vasculitis, decrease in those with corticosteroid 
therapy.  
4.Platelets  
Increase in inflammation, decrease in lupus & drugs. 
 5. CRP41 
     CRP is also known as C - reactive protein. It is an acute phase 
protein present in hepatocytes and plays an important role to the body’s 
response to inflammation. 18,11,21,22.          
 For the below mentioned reason the protein is called as ‘C’reactive 
protein - Gram positive, somatic portion of pneumococci contains 
species specific carbohydrate known as ‘C’ substance (antigen), which 
forms precitipitate with a protein (β globulin) in the blood in acute 
inflammatory conditions. Its production is stimulated by  
               1. Bacterial infection 
               2. Inflammation  
               3. Malignancy  
               4. Tissue destruction.  
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          Rapid Serum  assays  are useful in early detection of acute 
inflammation17,22,23,25. Increase of CRP denotes - onset of inflammation.  
Rapid decrease occurs when infection subsides. It is a close mirror of 
degree of inflammation.                 
          CRP detection  was  done  by  method   of  latex agglutination 
test.It must be noted that even in known cases of inflammatory disease, 
such as RA and lupus, a low CRP level is possible, and is not 
indicative of no inflammation. CRP appears and disappears more 
quickly. Therefore, CRP level may drop to normal following successful 
treatment. CRP test is also used to assess the effectiveness of a specific 
arthritis treatment and monitor periods of disease flareup. Its value is 
as a general indicator of response to treatment and not specific to 
rheumatoid arthritis. 
           Another blood test often ordered in conjunction with CRP is 
known as ESR.Both CRP and ESR give similar information about non-
specific inflammation. 
6. ESR 23,25,22,6 Erythrocyte Sedimentation Rate:  
            It is an indirect measure of the APR – Acute Phase Reaction.It 
chan ges from very low to very high levels, mirrors the degree of 
inflammation, rise rapidly at onset, & fall as inflammation subsides.So 
it is a direct measure of the APR.  Erythrocytes donot clump normally 
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due to their repellent electrostatic negative charge or zeta potential 
greater than the attractant electrical charge of the plasma constituents.     
In APR altered plasma protein concentrations- fibrinogen, increase in 
dielectric constant overwhelm the zeta potential & allow erythrocytes 
to clump (rouleaux).So it sediment fastly, which is measured as ESR. 
            ESR doesn’t appear and disappear more quickly and may 
remain elevated for a longer period. ESR increases in APR,Increased 
level of immunoglobulin,Myeloproliferative disorders & Autoimmune 
isorder. 
7. RF 
             RF is an autoantibody directed to the Fc part of IgG 
molecules.6,3,7,16. These antibodies are found in RA, in several other 
auto immune  diseases  and  as well as in healthy individuals - 5-10 % 
6,11 (in elderly people). This  lowers  its  specificity. 
            RF is  detected  by  the  method  of  latex  agglutination   test. 
8.Anti CCP Test  
            Antibody to cyclic citrullinated peptide,detected by  ELISA  
technique. 
Treatment: 26,30,31 
            Chemically synthesised DMARDs - (disease modifying anti 
rheumatic drugs) 
28 
 
 Azathioprine 
 Ciclosporin(cyclosporin A) 
 D- penicillamine 
 Gold salts 
 Hydroxychloroquine  
 Leflunomide  
 Methotrexate (MTX) 
 Minocycline 
 Sulphasalazine(ssz) 
Low dosages of daily cortisone (e.g., prednisone)are added to a proper 
specific anti-rheumatic treatment.  
2. Cytotoxic drug 
• Cyclophosphamide 
3. Biological agent 
• Tumor necrosis factor alpha (tnfα) blockers 
etanercept, infliximab, adalimumab. 
• Interleukin 1 (IL-1) blockers 
• Monoclonal antibodies against B cells - rituximab 
• T cell costimulation blocker  
• Interleukin 6 (IL-6) blockers  
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4. Anti inflammatory drugs 
• Glucocorticoids  
• Non-steroidal anti-inflammatory drug 
5. Analgesics  
                Paracetamol, Opiates, Diproqualone  and   Lidoquine  
 6. Also includes rest and physical activity. 
Osteoarthritis 30,31 
      Osteoarthritis (OA) is the most common type of arthritis.  
Definition 
       OA is joint failure, in which all structures of the joint have 
undergone pathologic change, often in concert. Pathologically it is 
defined as a condition of synovial joints characterised by focal loss of 
hyaline articular cartilage with proliferation of new bone and 
remodelling of joint contour. It involves both small and large joints. 
Prevalence  
       OA is uncommon in adults under age 40 and highly prevalent in 
those over age 60. But  steady rise from age 30, such that by 65, 80% 
will develop symptoms.Prevalence is high especially in the elderly. 
The Prevalence is increasing nowadays. 
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Risk factors:  
• Constitutional susceptibility 
               Ageing, Heredity, Gender, Hormonal status &Obesity. 
• Mechanical factors 
              Trauma  & Joint shape alignment usage - Occupational          
or  recreational. 
Commonly affected joints 
• Hip & Knee joints are commonly affected. 
• Also cervical and lumbo sacral spine. 
• In the hands, the distal and proximal interphalangeal joints 
and the base of the thumb are often affected.  
• First metatarsal phalangeal joint (MTP). 
• Usually spared are the wrist, elbow, and ankle. 
Pathology & Etiology 
• Mechanical  
• Metabolic  
• Genetic or  
• Constitutional insults damage the synovial joint  
           Panarticular  involvement is present. Cartilage initially shows 
surface fibrillation irregularity and focal erosions develop outgrowths 
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of new cartilage and with neurovascular invasion from the bone, this 
cartilage ossifies. Osteophytes are an important radiographic hallmark 
of OA.  The   capsule which stretches, becomes edematous, and can 
become fibrotic. 
Clinical Features 
            Joint pain from OA is activity-related. Pain comes on either 
during or just after joint use and then gradually resolves and relieved 
by rest. In knees, buckling may occur. Heberden’s node are present. 
Diagnosis 
            Diagnosis based upon Structural abnormalities or on the 
symptoms they evoke. 
• Symptoms  -  usually  joint  pain, determine  disability.  
• Structural abnormalities - Cartilage loss and osteophytes.  
Examination of  the  synovial  fluid  is  often  more  helpful  
diagnostically  than  an x-ray. 
Treatment 
Nonpharmacotherapy 
Since OA is a mechanically driven disease, ways of lessening focal 
load across the joint include 
  (1) Avoiding activities that overload the joint,  
  (2) Improving the strength and conditioning of muscles                     
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      that bridge the joint. 
Pharmacotherapy 
 Acetaminophen, 
 Non steroidal Anti-Inflammatory Drugs (NSAIDs), and  
 COX-2 Inhibitors. 
 Intra articular Injections: 
• Glucocorticoids and Hyaluronic Acid, and  
 Surgery. 
Systemic lupus erythematosus (SLE) 44,30,31 
Definition  
          SLE is an autoimmune disease in which organs and cells 
undergo damage mediated by tissue-binding autoantibodies and 
immune complexes. 
Prevalence 
          90% of patients are women of child-bearing age group. Both  
sexes, all ages, and all ethnic groups are susceptible. Prevalence in the 
United States is 15–50 per 100,000; the highest prevalence among 
ethnic groups studied is in African Americans. 
Etiology and Pathogenesis  
           Interactions between susceptibility genes and environmental 
factors result in abnormal immune responses. Cell antigens, 
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autoantibodies, and immune complexes persist for prolonged periods 
of time, allowing inflammation and disease to develop Anti nuclear 
antibodies, and Anti ds DNA. SLE is a multigenic disease. 
Diagnostic Criteria 
• Malar rash 
• Discoid rash 
• Photosensitivity 
• Oral ulcers 
• Arthritis 
• Renal disorder 
• Haematological disorder and Anti nuclear antibodies. 
Treatment  
• NSAID 
• Topical sunscreen 
• Methotrexate 
• Glucocorticoids  
• Methyl prednisolone 
• Cyclophosphamide 
• Azathioprine 
• Hydroxychloroquine. 
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MATERIALS & METHODS 
Study Design:                            
        This is a combined Cross Sectional, Case Control, and 
Prospective study. 
Study Place and Study Period: 
          The present study was conducted at the Microbiology Diagnostic 
Laboratory, Coimbatore Medical College Hospital, Coimbatore. This 
study period extended from June 2009 to May 2010.  
Study Subjects:  
          The total number of subjects in this study for evaluation were 
250, which included both males and females.The study subjects were 
selected according to the inclusion criteria’s mentioned below, from the 
patients who attended the Out Patient Clinics at the Rheumatology and 
Orthopaedics Department and Healthy Blood Donors who attended the 
Blood bank, Coimbatore Medical College Hospital, Coimbatore. 
          The study subjects, in both genders were divided into five 
groups. Each group include 50 patients. Four groups based upon the 
clinical conditions and fifth group, healthy individuals (blood donors) 
as control, as follows. 
Group I:  
           Rheumatoid Arthritis (RA) - 50 patients.  
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Group II: 
           Early Synovitis (ES) - 50 patients. 
Group III: 
            Connective   Tissue   Disorders   including   Systemic   Lupus   
Erythematosus (SLE) - 50 patients. 
Group IV: 
           Osteo Arthritis (OA) - 50 patients, and 
Group V: 
           Healthy  Blood  Donors (HBD) - 50 patients.  
INCLUSION CRITERIA: 
Early Synovitis:  
• Patients  with  complaints  of  joint  pain.  (Synovitis - joint 
pain, blotted feeling, redness, fever for > 6wks & < 12 
months duration.)5,18,19 
• Joint pain with no h/o injury or sepsis1 
• Without any bony deformity. 
• Not already on treatment for RA. 
(Inclusion19of  patients fulfiling ≥ 2 clinical and  ≥1 laboratory 
criterion and duration of symptoms ≤ 12 weeks. 
Clinical:  
Absence of  trauma ,Joint swelling in at least 1 joint, Joint pain in at 
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least 1 joint, Morning stiffness > 60 minutes. 
Laboratory:              
        Positive Rheumatoid Factor, ESR > 20 mm/h & CRP > 5 mg/L 
 CTD (SLE): 
• Arthritis along with vasculitis  
• Photosensitivity & 
• Malar rash 
OA: 
• Joint pain with no h/o injury or sepsis. 
• Brief morning stiffness (< 30mts) 
• Localised pain. Aggravated by use &relieved by rest.  
• No symmetrical involvement of joints. 
Healthy Blood Donors: 
              Healthy  persons  without any infection, or any communicable 
diseases. 
RA:   
              RA  patients were selected according to the ACR (American  
College of Rheumatology) criteria14.Criteria  a–d  must be present for 
at least 6weeks.To diagnose as RA any  4  of the  below  should  be  
present. 
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a.Morning 
stiffness 
Stiffness in and around the joints lasting 1 hr before 
maximal improvement 
b.Arthritis of 
 three or > joint 
areas 
At least 3 joint areas simultaneously have had soft tissue 
swelling or fluid (proximal interphalangeal, 
metacarpophalangeal, wrist, elbow, knee, ankle, and 
metatarso phalangeal joints) 
c.Arthritis of 
 hand joints 
Arthritis of wrist, metacarpo phalangeal joint, or proximal 
interphalangeal joint. 
d.Symmetric 
arthritis 
Simultaneous involvement of the same joint areas on both 
sides of the body. 
e.Rheumatoid 
nodules 
Subcutaneous nodules over bony prominences, extensor 
surfaces, or juxtaarticular regions observed by a physician 
f.Serum RF Positive serum Rheumatoid Factor 
g.Radiographic 
changes 
Typical changes of RA on postero anterior hand and wrist 
radiographs that must include erosions or unequivocal 
bony decalcification localized in or most marked adjacent 
to the involved joints. 
 
EXCLUSION CRITERIA: 
RA:    If does not fit in to the ACR criteria. 
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Early Synovitis: 
•      Complaints of joint pain (synovitis< 6wks & > 12months)  
•      Joint pain with h/o injury or sepsis.5 
•      With bone and joint deformity. 
• Already on treatment for RA.  
CTD:    Bony deformity without vasculitis. 
OA :     Joint pain with h/o injury or sepsis & Joint pain at rest. 
HBD:  Persons with any infection, or communicable  diseases. 
Sample for study: 
           Blood was taken after getting oral consent from Rheumatoid 
arthritis (RA), Early Synovitis (ES) & Connective Tissue Disorders 
including Systemic Lupus Erythematosus (SLE) patients from 
Rheumatology out patient clinics, and from Osteo Arthritis (OA) 
patients who attended the Orthopaedics out patient clinics,and also  
from the Healthy Blood Donors (HBD) who attended the Blood Bank. 
Serum was  separated from the blood and used as the sample. 
Collection of the Blood: 
           5 ml of Venous Blood was collected aseptically, divided into 
two portions.Three ml in a test tube with EDTA – for testing TC,DC, 
and ESR. And two ml in plain test tube (without EDTA) .Serum was 
separated and stored at – 20 0 C  for testing CRP,RF and Anti CCP.  
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ESR 22,23 25 
Method :  Westergrens method: 
              In a 200 mm capillary tube, patient’s blood was taken and 
kept stand still in erect posture. Results were read after one hour from 
the top column of the tube.Normal value   < 5-10 mm 
CRP 21,22,23,25 
Type of the Test:                                
       Latex Agglutination test 14 ( rapid slide test - qualitative)  
Principle of the test:  
              The test is based upon the immunologic reaction between CRP 
Antigen, and latex particles coated with mono specific  goat  
antihuman  CRP Antibodies, if positive indicated  by a distinctly 
visible agglutination of latex particles.if negative a smooth suspension 
is formed.  
Contents of the kit: 
           1. Latex reagent 
           2. Positive control 
           3. Negative control 
           4. Disposable slides   
           5. Disposable applicator sticks 
           6. Disposable plastic droppers& teats 
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Storage:     2 - 80  c. 
Specimen;  Serum (separated from blood) 
Do’s & Don’t’s: 
• All the reagents were brought to room temperature before testing. 
• Icteric, lipaemic or haemolysed samples were discarded. 
Procedure : 
• Pipetted one drop of Positive control, Negative control, and  
serum on the slide.  
• Added one drop of reagent on all sample and controls. 
• Mixed, and tilted the slide to and fro for 2 minutes, and read the 
results.  
Interpretation of Results:         
Interpretation   Observation 
Distinct coarse agglutination Within 0.5 mts(30 sec) - strong positive 
Fine agglutination After full 2 mts -  weak positive 
Smooth suspension Negative 
 
 Distinct agglutination indicates CRP content > than 6 mg /litre in 
undiluted serum specimen.                                                
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RHEUMATOID FACTOR 14 
Method of Detection:  Latex Agglutination test: 15 
Principle: 
Human globulin IgG is coated with latex particles. 
          Serum was mixed with latex reagent. Agglutination appears if 
the sample is positive for Rheumatoid factor. No agglutination appears 
and remains as smooth suspension, if the sample is negative 
forRF.(Latex coated with IgG + serum = IgG antibody binds with IgG 
& cause latex particles to flocculate.) It is a  rapid qualitative slide test. 
Contents of the kit: 
            1. Latex reagent 
            2. Positive control 
            3. Negative control 
            4. Disposable slides   
            5. Disposable applicator sticks 
            6. Disposable plastic droppers& teats 
Storage:   2 - 80c   
Specimen:  Serum, separated from blood. 
Do’s & Don’ts: 
• All the reagents were brought to room temperature before testing. 
• Icteric, lipaemic or haemolysed samples were discarded. 
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Procedure : 
• Pipetted one drop of Positive control, Negative control, and 
serum on the slide. 
• Added one drop of reagent on all samples and controls. 
• Mixed, tilted slide to and fro for 2 minutes, and  read the  results.  
Interpretation of results:  
 Distinct agglutination indicates RF content > than 20 IU RF/ml in 
undiluted serum.                     
 
ANTI-CCP ANTIBODY 
Name of the Kit Used: 
Anti-CCP antibody was studied with ELISA method11 by using 
GENESIS CPA (citrullinated protein antibodies) ELISA kit for 
detection of Rheumatoid arthritis specific Ig G antibodies to 
citrullinated protein. 
 
  Interpretation           Observation 
Distinct coarse agglutination    Within 0.5 mts - strong positive 
Fine agglutination After full 2 mts - weak positive 
Smooth suspension      Negative  
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Principle of the Test : 
• Diluted serum samples are incubated with Recombinant 
Citrullinated rat flaggrin immobilised on micro titre wells. 
• After washing away unbound components, Rabbit antihuman IgG 
conjugated to horseradish peroxidase is added to the wells and this 
binds to surface bound antibodies in the second incubation.  
• Unbound conjugate is removed by washing and a solution 
containing 3,3’, 5, 5”- tetramethylbenzidine and enzyme substrates 
added to trace specific antibody binding. 
• Addition of the stop solution terminates the reaction and provides  
the  appropriate pH for colour development. 
• The optical densities of the standards control and samples are 
measured using a microplate reader at 450 nm. Optical density is 
directly propotional to the concentration of citrullinated protein 
antibodies in the sample. 
Materials used for the test: 
           1.  Microplate – 96 wells 
           2. Sample diluent 
           3. Wash buffer  
           4. Conjugate   
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           5. TMB (tetramethylbenzidine ) substrate 
           6. Stop solution 
           7. Standards 
           8. Positive control 
           9. Negative control 
Storage of kit:  2-80C 
Preparation of Reagent: 
           1.  Diluted the sample diluent to 1:14 ratios in distilled water 
            2. Diluted the wash buffer to 1:9 ratios in distilled water. (50 ml 
wash buffer to 450ml of Distilled  water) 
Procedure: 
  Diluted   patients   sample   to  1:100   ratios   in    diluted               
 sample   diluent (10 µl serum +1ml Diluent). 
  Assembled   the   number    of    strips    required   for  the   
 assay. 
  Dispensed   100 µl   of    standard,   the    negative  control, 
positive  control  and   diluted   patient’s  sample  into  the    
appropriate  wells. 
 Incubated    for   30   minutes     at    room    temperature. 
 Decanted     the     contents     and     washed     the    wells    
3  times    with   wash    buffer    using   automated   washer  
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and didn’t   allowed   the  wells to dry. 
 Dispensed   100 µl   of   conjugate   into   each   well. 
 Incubated   for   30   minutes   at   room   temperature. 
 Decanted   the   contents    and    washed    the    wells   4 
times with   wash   buffer    using   automated   washer   and   
didn’t  allowed   the  wells  to dry. 
 Dispensed 100 µl  of    TMB    substrate   into    each   well. 
 Incubated   the   plates   for   10  minutes.  
 Added   100 µl   of   Stop   solution   to   each   well. 
 Took readings of the optical density of each well by using   
Microplate  Reader  within  10  minutes. (620nm reference 
filter is used.) 
Results: 
 Samples with OD ≥ OD (optical density) of 6.25 U/ml 
Standard are positive.      
 Samples with OD ≤ OD (optical density) of 6.25 U/ml 
Standard are Negative. 
  The    results  obtained   were   tabulated   and   analyzed. 
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RESULTS 
                   The present study was conducted with the patients who 
attended the Out Patient Clinics at the Rheumatology and Orthopaedics 
Department of Coimbatore Medical College Hospital, Coimbatore.  
200 subjects (including both males and females) were recruited for the 
study. The subjects were categorized into four groups – RA, ES, CTD, 
and OA (each group 50) based upon the clinical conditions, and 50 
Healthy Blood Donors who attended the Blood bank, Coimbatore 
Medical College Hospital, Coimbatore, were selected as control and 
categorized into fifth group. 
                  In the present study which was carried out on patients 
having various   arthritic   diseases,  
                  Age    wise    distribution    of     them   were   listed   in  
Table  and  chart – 1. 
                  Sex  wise  distribution of  various   arthritic  diseases -    
M/F ratio – RA - 1:2.33, ES –1:2.57, CTD – 1:2.12,  OA – 1:2.84   
was   tabulated   in   Table   and   chart – 2.  
                  Age / sex   distribution   of   various   arthritic   diseases   
were  listed  in  Table and chart – 3. 
Anti-CCP &  RF  test  results  in various arthritic diseases & HBD-                        
                Anti-CCP was positive  in  39  of 50 RA patients (78%),                    
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14 of 50 (28%)  Early Synovitis  cases, 2 of 50 (4%) CTD(SLE)  cases, 
,and none were positive among (50) OA  and (50) HBD, and lists of  
RF test results  were  38 of 50 RA patients (76%) ,  21 of 50 (42%) -  
ES patients, 11 of 50 (22%) - CTD including SLE patients , 6 of 50   
(12%)  - OA patients and  4 of 50 (8%) - of  HBD  were  positive  for 
RF were tabulated as  shown  in Table and  Chart – 4. 
               Sensitivity & Specificity of RF test in RA – (RF Positive in 
RA -38, NON RA 17) was 76% & 86%  respectively  was  tabulated  in  
Table  and  Chart – 5.                                 
               The sensitivity  &  Specificity  for  Anti CCP test for RA was 
78% & 98.6 % respectively  was  calculated  in  Table  and  Chart - 6. 
               Early synovitis was not included for the calculation of 
specificity in both RF and Anti CCP tests because it is an 
undifferentiated arthritis, can later convert  either into RA or non RA 
and cannot be categorized into a single group.                 
                The distribution of positivity’s of Anti CCP and / or  RF on  
the  groups  were – 
                 In RA - RF +ve and  Anti-CCP +ve ( both +ve)  were  -  33 
(66%),  RF -ve  and Anti-CCP +ve  were 6 (12%)  , RF+ve  and  Anti-
CCP -ve were 5 (10%), RF -ve   and  Anti-CCP –ve (both -ve) were 6 
(12%) were  listed   in the Table and Chart - 7. 
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                In CTD  (SLE)  RF +ve and  Anti-CCP +ve (both +ve)  were 
- 2 (4%), RF -ve  and  Anti-CCP +ve were nil , RF+ve  and  Anti-CCP  
-ve  were  9 (18%), RF -ve  and  Anti-CCP -ve (both -ve)   were 39 
(78%) were listed  in  the Table  and Chart - 7.               
                In  OA - RF +ve and  Anti-CCP +ve (both +ve)  were -  nil, 
RF -ve  and Anti-CCP +ve were nil, RF+ ve and Anti-CCP -ve were    
6 (12%),  RF -ve  and Anti-CCP -ve (both -ve)   were  44 (88%) were 
listed in the Table and Chart - 7. 
               Also in HBD  - RF +ve and  Anti-CCP +ve( both +ve)  were  
-  nil, RF -ve  and Anti-CCP +ve were nil, RF+ve and  Anti-CCP -ve 
were 4 (8%), RF -ve  and Anti-CCP -ve (both -ve)  were 46  (92%)  
were  listed  in  the  Table   and Chart - 7. 
              In 50% of Sero Negative RA patients Anti CCP Test was 
positive  (among 12 RF  Negative  cases 6 were positive)  as  listed  in 
Table and Chart – 8.   
              The Anti CCP & RF test results for ES (Anti CCP was 
positive in 14 & RF+ve in 21) were tabulated in Table  and Chart – 9.  
              Sensitivity,  Specificity,  PPV (positive Predictive value) & 
NPV (Negative Predictive value) of  
               Anti CCP (78%, 98.6%, 95.1% & 93%)  
               RF             (76%, 86%, 64.4% & 91.4%)  
49 
 
               Anti CCP and RF  (66%, 98.6%, 94.2% & 89.7%)  
               Anti CCP / RF     (88%,86%,67.7% & 95.5%) Tests were 
listed in   Table and Chart – 10. 
                 From  the  above  results, of all the above different arthritic 
diseases, Anti CCP is more sensitive and more specific for RA and RF 
is almost equally  sensitive but  less specific for RA.   
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TABLE – 1 
Age wise Distribution of various Arthritic Diseases 
Category Age 20-30yrs Age31-40yrs Age41-50yrs Age 51-60yrs 
RA     50) 7 12 14 17 
ES     (50) 10 16 16 8 
CTD   (50) 8 18 18 6 
OA     (50) 2 13 24 11 
 
  TABLE – 2 
            Sex wise Distribution of various Arthritic Diseases 
CATEGORY M % F % M/F Ratio 
RA     (50) 15 30 35 70 1: 2.33 
ES     (50) 14 28 36 72 1: 2.57 
CTD   (50) 16 32 34 68 1: 2.12 
OA     (50) 13 26 37 74 1: 2.84 
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TABLE –3 
Age/Sex Distribution of various arthritic groups 
CATEGORY Age 20-30yrs Age 31-40yrs Age 41-50yrs Age 51-60yrs 
 M F M F M F M F 
RA     (50) 2 5 5 7 4 10 4 13 
ES     (50) 2 8 4 12 5 11 3 5 
CTD   (50) 2 6 6 12 6 12 2 4 
OA     (50) 0 2 3 10 6 18 4 7 
 
TABLE – 4 
Anti-CCP & RF Results in various ArthriticDiseases & HBD 
CATEGORY Anti CCP  Positivity RF Positivity 
RA     (50) 39 (78%) 38 (76%) 
ES     (50) 14 (28%) 21 (42%) 
CTD   (50) 2 (4%) 11 (22% ) 
OA     (50) 0 6 (12% ) 
HBD   (50) 0 4 (8% ) 
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TABLE - 5 
Sensitivity & Specificity of RF Test in RA 
RF Positive Negative  
 
Total  
RA(50) 38 12 50 
Non RA (150) 
SLE+ OA + HBD  
21 129 150 
Total  59 141 200 
 
          Sensitivity    76%                                                Specificity 86  % 
ES not included because of undifferentiated state. 
TABLE- 6 
Sensitivity & Specificity of Anti CCP Test in RA 
TEST Anti ccp Positive Anti ccp Negative Total  
RA(50) 39 11 50 
Non RA(150) 
SLE+ OA + HBD 
2 148 150 
Total  41 159 200 
 Sensitivity:    78%                                                 Specificity:  98.6 % 
ES not included because of undifferentiated state. 
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TABLE-7 
Distribution of Positivities of Anti CCP and /or RF on the groups 
 In RA patients 
n = (50) 
SLE 
n = 50 
OA 
n = 50 
Control groups 
(HBD)  n = 50 
Anti CCP positive 39 2 0 0 
         RF positive 33 (66%) 2 (4%) 0 0 
          RF negative 6 (12%) 0 0 0 
     
Anti CCP negative 11 48 50 50 
         RF positive 5 (10%) 9 (18%) 6 (12%) 4 (8%) 
    RF negative 6 (12%) 39(78%) 44(88%) 46 (92%) 
 
TABLE – 8 
Use of Anti CCP Test in Sero Negative RA patients 
Anti CCP Sero Negative (RF-ve)  RA(12) 
Positive 6 
Negative 6 
 
50 % of seronegative arthritis cases are positive for anti CCP. 
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TABLE – 9 
Anti CCP& RF Test Results in ES Patients 
TEST Positive in ES (50) 
Anti CCP 14 
RF 21 
 
To be followed up further to confirm the convertability to established 
RA.                     
                      
TABLE-10 
Sensitivity, Specificity, PPV & NPV of Anti CCP & RF tests 
Tests Sensitivity  % Specificity   % PPVTest % NPV test % 
Anti CCP 78 98.6 95.1 93 
RF 76 86 64.4 91.4 
ANTI CCP & RF 66 98.6 94.2 89.7 
ANTI CCP /RF 88 86 67.7 95.5 
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DISCUSSION 
              RA is associated with only a few specific auto antibodies, 
including APF, AKA and anti-CCP and several less specific auto 
antibodies including RF4. Despite a well-documented lack of 
specificity, RF continues to be a serological test for RA because of its 
inclusion in ACR criteria. However to date no single autoantibody has  
demonstrated adequate positive diagnostic value to form the basis of 
clinical decisions. So auto antibodies present in RA, Early Synovitis, 
connective tissue disorders including SLE and OA have been evaluated 
in the present study, mainly for their diagnostic value. 
              The modern trend in management of  RA is to start the 
treatment as early as possible, based on the concept that early control 
of inflammation results in reduced joint damage. If undiagnosed the 
patients will not get treatment at an early date or if  wrongly diagnosed 
as RA , will be  unnecessarily treated with Anti Rheumatic drugs. It is 
therefore important to differentiate between RA and other forms of 
arthritis early, before the onset of symptoms. 
               In recent research by Schellekens GA,17 he has observed the 
diagnostic significance of a novel RA specific autoantibody, 
determined by ELISA  using synthetic peptides containing citrulline. 
The present study was done to determine the sensitivity and specificity 
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of  the RF and anti CCP antibodies, alone or in combination in relation 
to RA & other arthritis. 
              In the present study which was carried out on patients having 
different Arthritic diseases, Anti CCP test results suggest the 
significance of anti CCP positivity in diagnosis of RA and 
differentiating RA from other arthritis. To minimize the errors patients 
were selected according to the inclusion criteria’s. 
             For specificity calculation of RA, other arthritis and control 
groups were included, but ES was not included because it is in an 
undifferentiated form (not confined to any single entity, which may 
later convert into RA or other form of arthritis). 
             Of all the above different Rheumatological diseases, Anti CCP 
was more sensitive and more specific for RA, whereas RF was almost   
equally sensitive but less specific than Anti CCP for RA, because it is 
positive in other arthritic diseases and healthy persons also. 
            The results were in agreement with other studies in which the 
Anti CCP was positive in RA, ES and CTD including SLE, but the RF 
was non specific and present in all groups including control.  
Age/Sex distribution of various Arthritic diseases: 
Age :  
 In RA age group 51-60 years were more affected than other groups. 
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In age group31-40yrs and 41-50yrs ES & CTD were more common. 
OA was very common in age group 41-50yrs .The incidence of all 
types of arthritis is very low in age group of 20-30 years. 
Sex 
M/F ratio - in RA - 1: 2.33, ES –1: 2.57, Connective tissue Disorder 
(SLE) –1: 2.12, and in OA was -1: 2.84. Males are less affected than 
the females in all arthritic diseases.  
Sensitivity of RF in RA: 
            On analyzing the sensitivity of RF, the present study shows 
76% sensitivity in RA patients. This goes in parallel with the study by 
Lee and Schur et al 24 who found a sensitivity of 71.6% for RF.    
            The findings  of  the present study is comparable  with  the 
findings of the previous studies by Ulrich Sauerland et al 24 with 
69.7%  sensitivity, Raphaela Goldbach-Mansky et al 45  with 66% 
sensitivity, But in the studies by Munevver Serdaroflu et al 25, he 
observed 65% sensitivity ,Sibel Altun et al5  observed 60% sensitivity, 
K.P. Machold et al19 55% sensitivity,Nehir Samanci et al 11 44.8% 
sensitivity, J. van Aken et al 12 41% sensitivity . Sensitivity for RF was 
higher in the present study than the previous studies. This discrepancy 
may be due to method of selection of cases, and type of kits used for 
testing.               
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              In contrast a study by Dubucquoi et al.24 showed 94% 
sensitivity for RFwhich is higher than the present study.The 
controversy may be due to low sample size, and short period of study.  
Specificity of RF 
               In the present study specificity of  RF was 86%, which is in 
consistent with the study by Sibel Altun et al5 which showed the 
specificity of RF as 86.4%. But a study by Lee and Schur24 observed 
specificity of  80.3% which is  lower than the present study. 
              In Dubucquoi et al 24 study the specificity of RF was 53% 
only. The indifference may be due to small sample size because the 
study was carried out as a cross sectional study which  included 
different groups, and also may be  due to short duration of study. 
Sensitivity of  Anti CCP  
              The  sensitivity of Anti CCP  is  78% in the present study. 
This result was similar to the previous studies by Dubucquoi and 
colleagues16 which showed 77% sensitivity for ACCP, Ulrich 
Sauerland et al 24 study  showed 74% sensitivity  and  Sibel Altun et 
al 5 observed 70% sensitivity . Dubucquoi et al.24  observed a 
sensitivity of 85% which was higher than the present study. This 
difference may be due to small sample size of the present study 
because the study was carried out as a cross sectional study including 
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different groups, and may also be  due to short duration of study.        
             In the present study Anti-CCP positivity is 78% in RA 
patients  which is higher than  the  studies by K.P.Machold et al19 
and Bizzaro et al,  which showed only 41%positivity. Nehir Samanci 
et al11 observed 49.0% sensitivity, and J. van Aken et al 12 50% 
sensitivity, Lee and Schur24 found  66% sensitivity, Münevver 
Serdaroflu et al 25, and Raphaela Goldbach-Mansky et al 45 found 
50% sensitivity,and Jensen et al 5,23 also showed  55.4% sensitivity. 
The disparity may be due to the usage of different types of kits for 
testing (advanced kits) and small sample size.  
Specificity for Anti-CCP 
              In the present study specificity for anti-CCP is 98.6%, which 
is similar to the study by Sibel Altun et al 5. with 98.6% specificity. 
The present study goes in parallel with the previous studies by Bizzaro 
et al.5&Gerard A. Schellekens et al 8 both showing 98% specificity, 
and Dmitry Karayev et al 39 97% specificity.  Lee and Schur24 & 
Raphaela Goldbach-Manskyet al45 observed 90% specificity and 
Jensen et al 5,23  96.7% specificity. 
             But the studies by Nehir Samanci et al11 found 99% 
specificity, and Münevver Serdaroflu et al 25 showed 100% 
specificity for anti-CCP which was higher than the present study.This 
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discrepancy may be due to sample selection criteria’s and type of kits 
used for testing. 
Sensitivity of both RF & Anti CCP  antibody 
              In the present  study  both  RF and  Anti-CCP were positive  
in (66%) 33 of 50 RA patients. The results are  comparable with the 
study by Sibel Altun et al5 who showed 59.3% positivity. This value is 
higher than the  study by Schellekens et al 5 who found both anti CCP 
and RF positivity as (39%) 58of 149 RA cases. In  contrast a study by 
Dmitry Karayev et al 39 showed 99.6% sensitivity. 
This may be due to prompt selection of cases in the present study and 
using advanced type of kit.                      
              Anti-CCP or RF Positive (any one +ve)  in the present study 
is (88%) which is higher than the study by Bizzaro et al 5 who 
reported 31.6% positivity in (31 of the 98) RA patients.  
Specificity of both Anti CCP & RF: 
              The present study results were similar with the study by Sibel 
Altun et al5 who showed 98.6%  specificity for both tests positive in 
combination. 
 CTD (SLE) 
Anti CCP in CTD (SLE)          
             In CTD including SLE only 2 of 50 (4%) were anti-CCP 
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positive which is similar to the study by Sibel Altun et al5 showing 1 
of 25 (4%)  as positive in SLE patients.In an another study by 
Medivake et al5. 3 of 231(1.2%) SLE patients were anti CCP positive. 
Hoffman IE46and Ulrich sauer land 24 study and a recent article by 
Gottenberg et al.24 also confirmed the lesser prevalance of anti CCP 
in SLE.                             
              In a study by RDL 10 anti CCP positivity in SLE was 9.7%. 
which is higher and not in agreement with the present study. In contrast 
O Kasapcopur et al 28 study showed absence of anti-CCP antibody  
which is also not in agreement with the present study. The 
indifference might have over come if the study was carried with large 
sample size, and for a period of long duration. 
RF in SLE 
               Likewise in the present study with SLE - RF was positive in 
11 of 50 (22%)  which goes in parallel with the study by Sibel Altun et 
al5 with 20% positivity.These  results indicate that anti-CCP  antibody  
assay can be a useful indicator in differentiating SLE from RA than RF 
test. 
Other Arthritis (OA) and HBD: 
               The   present  study  results  showed  none  of  the  OA  and 
Healthy Blood Donors had positive Anti-CCP values which is in 
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positive  correlation with the  study by Sibel Altun et al5  who also 
observed that  none of the OA and Healthy Blood Donors had positive 
anti-CCP values. 
               Another study by Nehir  Samanci et al 11 showed only one as 
(1.2%) anti-CCP positive in the control group which is not in 
consistent with the present study. Absence of anti CCP antibodies in 
OA and HBD signifies its specificity in RA and will help in excluding  
them from RA. 
               In the present study RF was positive  in  6 of 50 (12% ) OA 
patients (all the 6 were anti CCP –ve)  and in 4of 50 (8%) HBD, which 
goes in agreement with the study by Sibel Altun et al 5 showing (10%)  
RF  positivity in OA patients and 10%  in HBD. The results denotes 
the non specificity of RF because of its presence in healthy persons 
and other arthritic cases. 
                Another study by Nehir Samanci  et  al 11 shows 44.8%  RF  
positivity in OA cases and 4.8% in controls which is higher than the  
present study.  This disparity of the results could be due to age mis- 
matched controls and small sample size (due to categorization of 
subjects into many groups). An ideal control population would have 
been an age-matched normal control population. 
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RF –ve (sero negative): 
              In the present study 6 of 12 (50%) sero negative patients were 
positive for anti CCP, this goes in parallel with Eric-Jan J. A. et al 14 
study which showed 43%anti CCP positivity. Similarly in a study by  
Kroot EJ, and a Vallbracht et aI,16 40% of seronegative patients were 
anti-CCP-positive which substantiates the additional diagnostic 
potential of Anti CCP in seronegative patients also.In another study by 
Quinn et al 18 sensitivity was 60%, which is higher rate than the 
present study. 
             Gerard A. Schellekens et al 8 study shows 35% specificity 
and in a multicentre study 18 &a study by Munevver Serdaroflu et al      
25  the specificity was 20%.Even though the % is less, it also showed  
the anti CCP positivity in seronegative patients, signifies the diagnostic 
potential of anti CCP  which will be helpful in treating the undiagnosed 
or missed diagnosis (seronegative) cases  of  RA and can prevent the 
post sequlae.   
             If positive, the anti-CCP test is an important surrogate marker 
especially for RF-negative RA. 
ES : 
            In   the present study 14 of the 50 ES patients were positive for 
Anti CCP and 21 of 50 were +ve for RF. A study by Sibel Altun et al5 
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showed that a strong correlation was observed between Anti-CCP and 
RA and in ES patients. (5 of the 18 ES patients who were positive for 
Anti-CCP were subsequently diagnosed to have RA. None of the 
remaining Anti-CCP-negative 13 patients developed RA.) Similarly                          
Bizzaro et al.  and Visser  et al.5 also  found a correlation between 
Anti-CCP  and RA in ES patients. Jansen et al 5 study  revealed a 
sensitivity of 55.4% and a specificity of 96.7%. In dubucquoi and 
colleagues24 study the sensitivity was 65% (at 96% specificity).  
           Annemarie et al, also concluded in their study that the 
positivity of Anti-CCP is an important indicator in the discrimination 
of early diagnosis of RA from undifferentiated polyarthritis. In a study   
by Vangalen17 83% of anti CCP positive patients,and in a study by 
viteuco et al 90% of anti CCP positive patients, at base line  fulfilled 
the ACR criteria after 1 year  follow up.in Vangalen study 93%  
fulfilled the ACR criteria after 3 years followup. 
            The above studies signifies that the Anti CCP is of more value  
in early diagnosis of  Rheumatoid  arthritis especially in ES patients 
even before the symptoms appear. So anti CCP positivity (biomarker)  
in ES helps as an early predictor in  diagnosing (future) RA. 
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Sensitivity, Specificity, PPV & NPV of Anti CCP & RF tests in RA:  
Sensitivity, Specificity,  PPV & NPV of  
 
Anti CCP              - 78%,     98.6%,     95.1%    & 93%  
RF                       -  76%,    86%,       64.4%     & 91.4%.  
Anti CCP & RF    - 66%,    98.6%,     94.2 %    & 89.7%. 
ANTI CCP / RF    - 88%,     86%,       67.7%     &  95.5.%.  
           The results obtained from the study shows that Anti CCP  test 
alone is more sensitive and specific for RA, and RF is equally sensitive 
but less specific than anti CCP test.  
            Anti CCP and RF  - both positive  was moderately   sensitive  
and  equally  specific  for RA (similar to anti CCP),  less sensitive and 
more  specific than RF alone,and Anti CCP/ RF. But  Anti CCP/ RF  - 
any one test positive   was  more sensitive  and  less specific than the 
combination of both tests and  Anti CCP test alone and more sensitive 
but equally specific  when compared to RF test alone.  
           This shows that the  anti- CCP positivity  gives additive value as 
a diagnostic test for RA and the combination of tests are valuable as a 
diagnostic tool in RA and  in differentiating or excluding it from other 
arthritis.  Majority of the previous studies  show  greater  significance  
of anti CCP  in RA,and  ES (undifferentiated arthritis)  as  a  diagnostic  
tool  and  early  predictor in ES, also in  excluding  them from non RA. 
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Limitation 
This study is mainly a cross sectional study, with various groups  of 
small  sample size. The period of study is also short so limiting the 
follow up to observe  the convertibility  of ES into established RA and 
non RA and to assess the prognosis in confirmed RA.  
 A large sample size, and a longitudinal study with periodical follow up 
will definitely be of greater  value in  prediction of anti CCP positivity.  
 Future scope of the present study                             
• The study can be further extended to involve different types 
of kits to test their sensitivity and specificity, for better 
prediction.  
• The study can be made clinically relevant in comparing with 
erosiveness/deformity with the anti CCP values. 
• Further research should be conducted to identify risk factors 
for aggressive disease, using serological as well as clinical 
markers. 
• Studies with repeated assessments of biomarkers prior to RA 
development may provide further insight into the timing of 
biomarker elevation in preclinical RA.  
Hope further research will reveal the significance of protein 
citrullination in the immunopathology of RA. 
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SUMMARY 
• In  the  present   study, Anti CCP anti bodies  in  Rheumatoid  
Arthritis  and  other arthritis patients  were assessed and  also in    
 healthy blood donors as control. 
• The anti CCP test shows high  positive rate in RA patients than 
other arthritic disease patients, and negative in OA and in 
Healthy Blood Donors .This reconfirmed the better specificity of 
anti CCP test in RA and  thus it can be used as a diagnostic tool.  
• Anti-CCP antibodies determination, proved to be a powerful 
diagnostic tool,especially in sero negative (RF negative) patients.  
• Anti CCP was very sensitive in Early Synovitis also.This confims 
it’s importantance in the discrimination of early diagnosis of RA 
in undifferentiated arthritis. 
• Since Anti CCP positivity is very low in SLE it helps in 
differentiating RA from other connective tissue disorders 
including SLE patients. 
• Anti CCP was negative in OA and HBD. So it will be useful in 
excluding these cases from RA.  
• Even  though  RF is equally   sensitive  as  Anti CCP  in RA, it is 
less specific when compared with Anti CCP . 
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• Anti-CCP testing combined with RF testing has additional value 
over RF testing alone in patients with early undifferentiated 
arthritis. 
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CONCLUSION 
                 The ACPA era has just begun, and is creating a revolution in 
Rheumatology.  As per the findings of  the present study Anti CCP test 
is more sensitive and highly  specific. Anti CCP antibody is a very 
valuable serological indicator in diagnosis of RA.Besides being a 
specific marker in advanced RA, the anti CCP antibody in ES is a very 
important predictor (diagnostic marker) of RA. 
                Anti CCP has the hallmark of establishing as a diagnostic 
tool and provides additive sensitivity to RF. The presence of both RF 
and  Anti CCP  in serum is a strong indicator of  RA.  
                Association of Anti-CCP with other Connective Tissue 
Disorders including SLE is very low when compared to its significant 
association with RA.Thus it helps in distinguishing RA from other 
erosive disorders. 
                 Anti CCP is positive in 50% of Seronegative arthritis       
(RF negative) patients.Thus it proved to be a more sensitive diagnostic 
tool, which helps in detection (not missing the diagnosis) of RA,very 
early in course. 
                 Absence of Anti CCP in OA and HBD makes it more 
specific for RA.But the presence of RF to a lesser extent in the above 
conditions makes (RF) it less specific.                  
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                 In conclusion, based upon the higher sensitivity and 
specificity of the Anti CCP test in RA, the current study is of 
diagnostic, and public importance, because it suggests that Anti CCP 
test should be included in the investigation of undifferentiated arthritis, 
since a considerable amount of Rheumatic disease associated work 
disability starts in the first  few years of the disease. 
                   Anti-CCP antibodies have all the hallmarks of establishing 
themselves firmly in the diagnostic algorithm of Rheumatoid Arthritis 
providing additive sensitivity to Rheumatoid Factor. So it should also 
be included among the diagnostic criteria of RA along with RF. 
                  It can also be used as a prognostic indicator in RA patients 
on treatment.    
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Chart - 4. Anti-CCP& RF Test Results in all Arthritic groups & HBD 
 
 
 
Chart - 5.Sensitivity & Specificity of RF Test in RA 
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